VolitionRX Ltd. VNRX 深 滬
等待開盤 10-31 09:30:00 美东时间
0.4354
+0.005
+1.26%
華盛通- 最 高0.4699
- 今 開0.4468
- 成交量 92.75万股
- 最 低 0.43
- 昨 收 0.43
- 總市值 4528.16万
- 52周最高 0.94
- 市盈率 靜 --
- 換手率 0.89%
- 52周最低 0.3951
- 委 比 0.00%
- 總股本 1.04亿
- 歷史最高 9.28
- 量 比 0.73
- 振 幅 9.28%
- 歷史最低 0.3951
- 每 手 1
- 風險率 0.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs
HENDERSON, Nev., Oct. 17, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), and its subsidiary, Volition Veterinary Diagnostics Development LLC, in line with their ...
10-17 20:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 28.3% to $0.89 during Thursda...
10-10 05:06
VolitionRx proposes underwritten public offering of common stock, common stock warrants
VolitionRx (NYSE:VNRX) is proposing to offer and sell, in an underwritten public offering, shares of its common stock and accompanying common stock purchase warrants. The final terms of the proposed o...
10-10 04:14
VolitionRX shares are trading lower after the company announced a public offering.
VolitionRX shares are trading lower after the company announced a public offeri...
10-10 04:09
VolitionRx Announces Proposed Underwritten Public Offering Of Common Stock And Common Stock Warrants; No Terms Disclosed
VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to offer and sell, in an underwritten public offering, shares of its common stock
10-10 04:07
Volition Sponsors Upcoming GenomeWeb Webinar
HENDERSON, Nev., Oct. 2, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the sponsorship of a GenomeWeb webi...
10-02 20:45
美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.
09-30 00:37
Volition Signs Co-Marketing and Services Agreement with Hologic
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement w...
09-29 21:30
Volition Signs First Human Out Licensing Deal
HENDERSON, Nev., Sept. 9, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the signing of a Research License ...
09-09 20:45
